Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
CCGs are frequently in the news, and are criticised, for 'rationing' certain treatments on spurious grounds. These 12 CCGs should be lauded for increasing patient choice to include Avastin for wet AMD. Many will choose the cheapest option, for altruistic reasons, and big pharma would be unwise to prevent them doing so. As I asked when the issue was last raised here, why are Health Ministers and the UK CMOs silent?